GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Aphex BioCleanse Systems Inc (OTCPK:SNST) » Definitions » Equity-to-Asset

Aphex BioCleanse Systems (Aphex BioCleanse Systems) Equity-to-Asset : 0.00 (As of . 20)


View and export this data going back to . Start your Free Trial

What is Aphex BioCleanse Systems Equity-to-Asset?

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Aphex BioCleanse Systems's Total Stockholders Equity for the quarter that ended in . 20 was $0.00 Mil. Aphex BioCleanse Systems's Total Assets for the quarter that ended in . 20 was $0.00 Mil.

The historical rank and industry rank for Aphex BioCleanse Systems's Equity-to-Asset or its related term are showing as below:

SNST's Equity-to-Asset is not ranked *
in the Consumer Packaged Goods industry.
Industry Median: 0.54
* Ranked among companies with meaningful Equity-to-Asset only.

Aphex BioCleanse Systems Equity-to-Asset Historical Data

The historical data trend for Aphex BioCleanse Systems's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aphex BioCleanse Systems Equity-to-Asset Chart

Aphex BioCleanse Systems Annual Data
Trend
Equity-to-Asset

Aphex BioCleanse Systems Quarterly Data
Equity-to-Asset

Competitive Comparison of Aphex BioCleanse Systems's Equity-to-Asset

For the Household & Personal Products subindustry, Aphex BioCleanse Systems's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Aphex BioCleanse Systems's Equity-to-Asset Distribution in the Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Aphex BioCleanse Systems's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where Aphex BioCleanse Systems's Equity-to-Asset falls into.



Aphex BioCleanse Systems Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

Aphex BioCleanse Systems's Equity to Asset Ratio for the fiscal year that ended in . 20 is calculated as

Equity to Asset (A: . 20 )=Total Stockholders Equity/Total Assets
=/
=

Aphex BioCleanse Systems's Equity to Asset Ratio for the quarter that ended in . 20 is calculated as

Equity to Asset (Q: . 20 )=Total Stockholders Equity/Total Assets
=/
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Aphex BioCleanse Systems  (OTCPK:SNST) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.


Aphex BioCleanse Systems Equity-to-Asset Related Terms

Thank you for viewing the detailed overview of Aphex BioCleanse Systems's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Aphex BioCleanse Systems (Aphex BioCleanse Systems) Business Description

Traded in Other Exchanges
N/A
Address
1820 State Road 13, Unit 11-43, Saint Johns, FL, USA, 32259
Aphex BioCleanse Systems Inc is a United States-based company that provides sanitization solutions. It develops and manufactures non-alcohol, non-toxic, and hydrogen-based disinfecting technology. The company produces proprietary hydrogen-based disinfectant and pesticide products known as Hy-IQ Water.

Aphex BioCleanse Systems (Aphex BioCleanse Systems) Headlines

From GuruFocus